Related references
Note: Only part of the references are listed.Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy
Joseph R. Habib et al.
ANNALS OF SURGERY (2023)
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma
Manoj Amrutkar et al.
MOLECULAR ONCOLOGY (2023)
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
Avital Vorontsova et al.
ONCOGENE (2023)
Why the Treatment Sequence Matters Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas Cancer
Victoria S. Wu et al.
ANNALS OF SURGERY (2023)
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba et al.
NATURE COMMUNICATIONS (2023)
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
Kenji Kawahara et al.
CLINICAL & EXPERIMENTAL METASTASIS (2022)
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression
Carolina F. Ruivo et al.
GUT (2022)
Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis
Gaia Bellomo et al.
GUT (2022)
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells
Camilla Pecoraro et al.
MOLECULES (2022)
Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
Ryul Kim et al.
CANCER DISCOVERY (2022)
Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer
Hillary G. Pratt et al.
CANCERS (2022)
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition
Yutaro Tsubakihara et al.
MOLECULAR ONCOLOGY (2022)
Exosomes and their roles in the chemoresistance of pancreatic cancer
Yubin Pan et al.
CANCER MEDICINE (2022)
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy
Jiaqi Yang et al.
EBIOMEDICINE (2022)
Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer
Xiaobao Yang et al.
CANCERS (2022)
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Nino et al.
NATURE (2022)
Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy
Kendelle J. Murphy et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2022)
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L. Hwang et al.
NATURE GENETICS (2022)
Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
Max Heiduk et al.
JCI INSIGHT (2022)
Dysregulated FOXM1 signaling in the regulation of cancer stem cells
Gulab Sher et al.
SEMINARS IN CANCER BIOLOGY (2022)
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
Tom Van Nyen et al.
NATURE COMMUNICATIONS (2022)
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis
Erica Pranzini et al.
CELL REPORTS (2022)
Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer
Feifei Shen et al.
FRONTIERS IN ONCOLOGY (2022)
Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
Avital Klein-Brill et al.
JAMA NETWORK OPEN (2022)
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer
Andressa Dias Costa et al.
CLINICAL CANCER RESEARCH (2022)
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
Daniel Cui Zhou et al.
NATURE GENETICS (2022)
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
Duk Ki Kim et al.
NATURE COMMUNICATIONS (2022)
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Lea Monteran et al.
NATURE COMMUNICATIONS (2022)
Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study
Iago de Castro Silva et al.
ELIFE (2022)
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
Woohyung Lee et al.
BRITISH JOURNAL OF SURGERY (2022)
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty et al.
ANNALS OF SURGERY (2021)
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy
Theodoros Michelakos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer
Zongting Gu et al.
CANCER LETTERS (2021)
Spatially confined sub-tumor microenvironments in pancreatic cancer
Barbara T. Grunwald et al.
CELL (2021)
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer
Mingyang Liu et al.
GASTROENTEROLOGY (2021)
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer
Hui Peng et al.
CLINICAL CANCER RESEARCH (2021)
Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
Xu Wang et al.
NATURE COMMUNICATIONS (2021)
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages
Remi Samain et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
Huiqin Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer
Alexander Semaan et al.
BRITISH JOURNAL OF CANCER (2021)
The immunological impact of preoperative chemoradiotherapy on the tumor microenvironment of pancreatic cancer
Satoshi Okubo et al.
CANCER SCIENCE (2021)
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status
Kendelle J. Murphy et al.
SCIENCE ADVANCES (2021)
Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer
Julienne L. Carstens et al.
CELL REPORTS (2021)
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
Monika Graeser et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
Kai Chen et al.
EBIOMEDICINE (2021)
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma
Mikael oman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
Abudureyimu Tuerhong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
Bruno Bockorny et al.
CLINICAL CANCER RESEARCH (2021)
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade
Sebastian R. Nielsen et al.
NATURE COMMUNICATIONS (2021)
Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)
Rosa Wijnen et al.
CANCERS (2021)
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
Li-Heng Che et al.
CELL DISCOVERY (2021)
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
Andrew Woolston et al.
NATURE ECOLOGY & EVOLUTION (2021)
Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert et al.
NATURE REVIEWS CANCER (2021)
Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Carmen Mota Reyes et al.
CLINICAL CANCER RESEARCH (2020)
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
Mingyang Liu et al.
GASTROENTEROLOGY (2020)
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
Ziyu Li et al.
SCIENCE ADVANCES (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri et al.
JAMA SURGERY (2020)
Reshaping the tumor microenvironment: extracellular vesicles as messengers of cancer cells
Bibek Bhatta et al.
CARCINOGENESIS (2020)
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
Yu Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The potential roles of exosomes in pancreatic cancer initiation and metastasis
Wei Sun et al.
MOLECULAR CANCER (2020)
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
Monique B. Nilsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
Robert M. Samstein et al.
NATURE CANCER (2020)
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
Ying L. Liu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways
Jingjing Hou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Open Sesame?: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer
Ornella Randazzo et al.
CANCERS (2020)
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy
Matthew R. Farren et al.
JCI INSIGHT (2020)
The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment
Hongzhi Sun et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Small molecule inhibitors in pancreatic cancer
Jufeng Sun et al.
RSC MEDICINAL CHEMISTRY (2020)
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
Junya Peng et al.
CELL RESEARCH (2019)
Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
Hani M. Babiker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy
Luciana Nogueira de Sousa Andrade et al.
SCIENTIFIC REPORTS (2019)
Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Vincent Bernard et al.
CLINICAL CANCER RESEARCH (2019)
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M. Nywening et al.
GUT (2018)
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E. Hessmann et al.
GUT (2018)
FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma
Mashaal Dhir et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
Michael Timaner et al.
CANCER RESEARCH (2018)
Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen et al.
ONCOGENE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
Lusheng Wei et al.
CELL DEATH & DISEASE (2018)
Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
Z. Deng et al.
ONCOGENE (2017)
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
K. E. Richards et al.
ONCOGENE (2017)
Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest
Tao Peng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis
Yi Seok Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S. Karagiannis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art
Francesca Fanini et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine
Hiroyuki Takeda et al.
ANTICANCER RESEARCH (2016)
Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK
Paul A. Toste et al.
MOLECULAR CANCER RESEARCH (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
Shintaro Takeuchi et al.
CANCER RESEARCH (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer
Josep Tabernero et al.
ONCOLOGIST (2015)
Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness
Zhiwei Li et al.
CLINICAL CANCER RESEARCH (2015)
Slug-Dependent Upregulation of L1CAM Is Responsible for the Increased Invasion Potential of Pancreatic Cancer Cells following Long-Term 5-FU Treatment
Kaja Lund et al.
PLOS ONE (2015)
JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells
Shuhei Suzuki et al.
ONCOTARGET (2015)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy
Erez Hasnis et al.
NEOPLASIA (2014)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
An Undesired Effect of Chemotherapy GEMCITABINE PROMOTES PANCREATIC CANCER CELL INVASIVENESS THROUGH REACTIVE OXYGEN SPECIES-DEPENDENT, NUCLEAR FACTOR κB- AND HYPOXIA-INDUCIBLE FACTOR 1α-MEDIATED UP-REGULATION OF CXCR4
Sumit Arora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
Sophie Gourgou-Bourgade et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
Fiorenza Lotti et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions
Shyuichiro Matsubara et al.
SCIENTIFIC REPORTS (2013)
Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice
Svetlana Gingis-Velitski et al.
CANCER RESEARCH (2011)
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Davide Melisi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
K. K. Y. Cham et al.
BRITISH JOURNAL OF CANCER (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
Maria-Theresa Mueller et al.
GASTROENTEROLOGY (2009)
Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
Wu Huanwen et al.
MOLECULAR CANCER (2009)
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
Julie Guillermet-Guibert et al.
MOLECULAR CANCER THERAPEUTICS (2009)